Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Chen, Shih Hsin ^a   Chan, Sheng Chieh ^a   Chao, Yin Kai ^a   Yen, Tzu Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FALSE POSITIVE RESULT; FEMALE; HEAD AND NECK CANCER; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIMARY TUMOR; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TAIWAN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TAIWAN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896722614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082812     Document Type: Article

References (26)

1. (2012) Taiwan cancer registry annual report 2009. Taipei: Bureau of Health Promotion, Department of Health, Executive Yuan.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer. Available: http://globocan.iarc.fr. Accessed 9 August 2013
3. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, et al.SEER cancer statistics review, 1975-2010, National Cancer Institute. Bethesda, MD. Available: http://seer.cancer.gov/csr/1975-2010/. Accessed 9 Auguest 2013.
4. Poon RT, Law SY, Chu KM, Branicki FJ, Wong J (1998) Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 65: 1529-1534. doi:10.1016/S0003-4975(98)00177-5. PubMed: 9647053.
5. Kumagai Y, Kawano T, Nakajima Y, Nagai K, Inoue H et al. (2001) Multiple primary cancers associated with esophageal carcinoma. Surg Today 31: 872-876. doi:10.1007/s005950170025. PubMed: 11759880. (Pubitemid 33036158)
6. Kagei K, Hosokawa M, Shirato H, Kusumi T, Shimizu Y et al. (2002) Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 32: 120-127. doi:10.1093/jjco/hyf028. PubMed: 12072421. (Pubitemid 41289010)
7. Natsugoe S, Matsumoto M, Okumura H, Ishigami S, Uenosono Y et al. (2005) Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg 29: 46-49. doi:10.1007/s00268-004-7525- y. PubMed: 15592914.
8. van Westreenen HL, Westerterp M, Jager PL, van Dullemen HM, Sloof GW et al. (2005) Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 46: 1321-1325. PubMed: 16085589.
9. Vyas S, Markar SR, Iordanidou L, Read S, Stoker D et al. (2011) The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management. J Gastrointest Surg 15: 2127-2135. doi:10.1007/s11605-011-1686-4. PubMed: 21964582.
10. Malik V, Johnston C, Donohoe C, Claxton Z, Lucey J, et al. (2012) (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management. Clin Nucl Med 37: 1152-1158.
11. Barber TW, Duong CP, Leong T, Bressel M, Drummond EG et al. (2012) 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data. J Nucl Med 53: 864-871. doi:10.2967/jnumed.111.101568. PubMed: 22582047.
12. NCCN clinicsl practice guidelines in oncology - Esophageal and esophagogastric junction cancers. Version 2.2013. National Comprehensive Cancer Network. Available: http://www.nccn.org/professionals/physician-gls/pdf/ esophageal.pdf. Accessed 6 July 2013.
13. Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24: 729-735. doi:10.1111/j.1440-1746.2009.05824.x. PubMed: 19646015.
14. Choi JY, Lee KS, Kwon OJ, Shim YM, Baek CH et al. (2005) Improved detection of second primary cancer using integrated [18F]fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 23: 7654-7659. doi:10.1200/JCO.2005.01.4340. PubMed: 16234527. (Pubitemid 46291830)
15. Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y et al. (2013) Epidemiology of esophageal cancer in Japan and China. J Epidemiol 23: 233-242. Available online at: doi:10.2188/jea.JE20120162. PubMed: 23629646
16. Wu IC, Lu CY, Kuo FC, Tsai SM, Lee KW et al. (2006) Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur J Clin Invest 36: 236-241. doi:10.1111/j.1365-2362.2006.01621.x. PubMed: 16620285.
17. Oze I, Matsuo K, Suzuki T, Kawase T, Watanabe M et al. (2009) Impact of multiple alcohol dehydrogenase gene polymorphisms on risk of upper aerodigestive tract cancers in a Japanese population. Cancer Epidemiol Biomarkers Prev 18: 3097-3102. doi:10.1158/1055-9965.EPI-09-0499. PubMed: 19861527.
18. Ding JH, Li SP, Cao HX, Wu JZ, Gao CM et al. (2010) Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk for esophageal cancer in a Chinese population. J Hum Genet 55: 97-102. doi:10.1038/jhg.2009.129. PubMed: 20010786.
19. Matsuo K, Oze I, Hosono S, Ito H, Watanabe M et al. (2013) The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer. Carcinogenesis 34: 1510-1515. doi:10.1093/carcin/bgt080. PubMed: 23455379.
20. Gao CM, Takezaki T, Wu JZ, Zhang XM, Cao HX et al. (2008) Polymorphisms of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 and colorectal cancer risk in Chinese males. World J Gastroenterol 14: 5078-5083. doi:10.3748/wjg.14. 5078. PubMed: 18763293.
21. Seitz HK, Stickel F (2010) Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism. Genes Nutr 5: 121-128. doi:10.1007/s12263-009-0154-1. PubMed: 19847467.
22. Heusner TA, Hahn S, Hamami ME, Kim UH, Baumeister R et al. (2009) Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development. Eur Radiol 19: 2171-2179. doi:10.1007/s00330-009-1405-7. PubMed: 19415294.
23. Bhargava P, Rahman S, Wendt J (2011) Atlas of confounding factors in head and neck PET/CT imaging. Clin Nucl Med 36: e20-e29. doi:10.1097/RLU. 0b013e318212c872. PubMed: 21467845.
24. Cheng NM, Yu CT, Ho KC, Wu YC, Liu YC et al. (2009) Respiration-averaged CT for attenuation correction in non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 36: 607-615. doi:10.1007/s00259-008-0995-7. PubMed: 19050875.
25. Little SG, Rice TW, Bybel B, Mason DP, Murthy SC et al. (2007) Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg 31: 791-796. doi:10.1016/j.ejcts.2007.01.037. PubMed: 17337344.
26. Miyata H, Doki Y, Yasuda T, Yamasaki M, Higuchi I et al. (2008) Evaluation of clinical significance of 18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus. Dis Esophagus 21: 144-150. doi:10.1111/j.1442-2050.2007.00743.x. PubMed: 18269650. (Pubitemid 351247327)